IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,915,979 | -26.5% | 5,036,479 | +13.8% | 0.04% | -22.0% |
| Q2 2023 | $31,164,257 | +42.9% | 4,426,741 | +24.0% | 0.05% | +38.9% |
| Q1 2023 | $21,804,794 | +24.7% | 3,568,706 | +30.4% | 0.04% | +16.1% |
| Q4 2022 | $17,481,328 | -33.9% | 2,735,732 | -0.8% | 0.03% | -32.6% |
| Q3 2022 | $26,427,000 | -13.9% | 2,758,573 | -0.7% | 0.05% | -11.5% |
| Q2 2022 | $30,678,000 | -32.1% | 2,778,802 | +2.5% | 0.05% | -13.3% |
| Q1 2022 | $45,155,000 | -12.0% | 2,712,014 | +0.9% | 0.06% | -1.6% |
| Q4 2021 | $51,309,000 | -27.5% | 2,687,730 | -6.3% | 0.06% | -29.1% |
| Q3 2021 | $70,732,000 | -8.6% | 2,868,295 | -3.6% | 0.09% | -6.5% |
| Q2 2021 | $77,392,000 | -18.1% | 2,974,334 | -0.3% | 0.09% | -22.7% |
| Q1 2021 | $94,445,000 | -29.9% | 2,983,114 | +2.7% | 0.12% | -27.4% |
| Q4 2020 | $134,721,000 | +44.5% | 2,903,469 | +2.5% | 0.16% | +24.2% |
| Q3 2020 | $93,237,000 | +13.6% | 2,832,238 | -5.3% | 0.13% | +0.8% |
| Q2 2020 | $82,080,000 | +52.2% | 2,990,153 | +66.0% | 0.13% | +13.9% |
| Q1 2020 | $53,919,000 | +18.4% | 1,801,210 | +9.5% | 0.12% | +43.8% |
| Q4 2019 | $45,537,000 | +106.3% | 1,645,117 | +35.7% | 0.08% | +90.5% |
| Q3 2019 | $22,068,000 | -13.1% | 1,212,548 | +17.1% | 0.04% | -10.6% |
| Q2 2019 | $25,388,000 | – | 1,035,396 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |